Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 15 studies | 81% ± 19% | |
| glutamatergic neuron | 12 studies | 76% ± 19% | |
| GABAergic neuron | 11 studies | 70% ± 22% | |
| astrocyte | 9 studies | 34% ± 20% | |
| microglial cell | 7 studies | 33% ± 22% | |
| neuron | 6 studies | 46% ± 27% | |
| endothelial cell | 6 studies | 42% ± 18% | |
| interneuron | 6 studies | 77% ± 14% | |
| oligodendrocyte | 5 studies | 38% ± 25% | |
| granule cell | 4 studies | 42% ± 27% | |
| retinal bipolar neuron | 4 studies | 41% ± 19% | |
| retinal ganglion cell | 4 studies | 42% ± 9% | |
| GABAergic interneuron | 3 studies | 71% ± 17% | |
| amacrine cell | 3 studies | 45% ± 19% | |
| GABAergic amacrine cell | 3 studies | 70% ± 8% | |
| OFF-bipolar cell | 3 studies | 39% ± 14% | |
| ON-bipolar cell | 3 studies | 43% ± 17% | |
| glycinergic amacrine cell | 3 studies | 27% ± 2% | |
| rod bipolar cell | 3 studies | 45% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 16 studies | 50% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 401.23 | 2573 / 2642 | 93% | 7.77 | 659 / 705 |
| spleen | 92% | 200.47 | 221 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 3% | 2.24 | 7 / 258 | 46% | 1.17 | 105 / 230 |
| kidney | 24% | 22.85 | 21 / 89 | 2% | 0.07 | 14 / 901 |
| bladder | 0% | 0 | 0 / 21 | 15% | 0.52 | 74 / 504 |
| liver | 2% | 1.80 | 5 / 226 | 8% | 0.25 | 34 / 406 |
| skin | 0% | 0.03 | 1 / 1809 | 8% | 0.28 | 38 / 472 |
| pancreas | 1% | 0.59 | 2 / 328 | 6% | 0.42 | 10 / 178 |
| uterus | 0% | 0 | 0 / 170 | 2% | 0.08 | 11 / 459 |
| esophagus | 1% | 0.53 | 10 / 1445 | 2% | 0.02 | 3 / 183 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
| thymus | 0% | 0.33 | 3 / 653 | 1% | 0.02 | 4 / 605 |
| stomach | 0% | 0 | 0 / 359 | 1% | 0.02 | 3 / 286 |
| breast | 0% | 0.23 | 1 / 459 | 1% | 0.04 | 6 / 1118 |
| lung | 0% | 0 | 0 / 578 | 1% | 0.01 | 7 / 1155 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0.01 | 2 / 430 |
| intestine | 0% | 0 | 0 / 966 | 0% | 0.01 | 1 / 527 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007154 | Biological process | cell communication |
| GO_0032587 | Cellular component | ruffle membrane |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005622 | Cellular component | intracellular anatomical structure |
| GO_0016013 | Cellular component | syntrophin complex |
| GO_0016010 | Cellular component | dystrophin-associated glycoprotein complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| GO_0005198 | Molecular function | structural molecule activity |
| Gene name | SNTG1 |
| Protein name | Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4) Syntrophin gamma 1 |
| Synonyms | |
| Description | FUNCTION: Adapter protein that binds to and probably organizes the subcellular localization of a variety of proteins. May link various receptors to the actin cytoskeleton and the dystrophin glycoprotein complex (By similarity). May participate in regulating the subcellular location of diacylglycerol kinase-zeta to ensure that diacylglycerol is rapidly inactivated following receptor activation. . |
| Accessions | ENST00000642826.1 ENST00000642720.2 [Q9NSN8-1] H0YC21 ENST00000517473.5 [Q9NSN8-2] ENST00000520825.5 ENST00000643740.1 ENST00000524004.5 ENST00000647073.1 A0A2R8Y631 A0A2R8Y5G8 A0A2R8YGL5 E5RIN0 ENST00000643809.1 ENST00000523085.5 ENST00000643999.1 Q9NSN8 A0A2R8YF28 ENST00000642525.1 ENST00000518864.5 [Q9NSN8-1] A0A2R8Y7L6 ENST00000642377.1 E5RHN6 A0A2R8Y5T2 A0A2R8YDV6 A0A2R8Y7Z5 A0A2R8YFF5 A0A2R8Y457 ENST00000647273.1 A0A2R8Y6P6 ENST00000644093.1 A0A2R8Y668 A0A2R8Y7J9 ENST00000644723.1 ENST00000644469.1 ENST00000642286.1 A0A2R8YEF7 ENST00000646880.1 ENST00000642164.1 |